BIOXNasdaqAgricultural ChemicalsFiscal year ends June 30
Bioceres Crop Solutions Corp.
Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 20-F on Nov 10, 2025
$0.26−0.02 (-7.44%)
Close on Oct 19, 2026
- Market cap
- $16.19M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2016 to 2025
Gross margin
39.3%−6.6 pts over 5 years
Operating margin
-0.7%−23.3 pts over 5 years
Net margin
-16.5%−18.5 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -27.9% | +0.0% | +14.1% | – | |
| Gross profit | -29.4% | +1.4% | +10.6% | – | |
| Free cash flow | +38.6% | – | +42.0% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 7.2% | -19.1% | |
| Return on assets | – | 1.2% | -6.9% | |
| Current ratio | – | 1.26 | 0.91 | |
| Debt to equity | – | 2.27 | 0.59 | |
| Interest coverage | 0.0× | 1.9× | -0.1× | |
| Inventory turnover | – | 3.3× | 1.9× | |
| Capex to revenue | 1.5% | 1.0% | 1.7% | |
| Diluted shares | 28M | 36M | 63M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Bioceres Crop Solutions generated $117.93M from operations and spent $41.91M on capital expenditure, dividends and share buybacks. 79% of that went back into the business.
Generated
$117.93M
Used
$41.91M
Capital expenditure$33.06M79%Dividends$698.98K2%Share buybacks$8.16M19%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-16.5%
×Asset turnover0.41×
×Equity multiplier2.78×
=Return on equity, FY2025-19.1%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -16.5% | 0.41× | 2.78× | -19.1% |
| FY2024 | 0.9% | 0.56× | 2.72× | 1.4% |
| FY2023 | 4.5% | 0.63× | 3.14× | 8.8% |
| FY2022 | -2.2% | 0.73× | 4.68× | -7.4% |
| FY2021 | -3.3% | 0.61× | 6.08× | -12.1% |
| FY2020 | 1.9% | 0.64× | 5.78× | 7.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$55.42M
- Cash generatingOperating cash flow above zero$49.91M
- Return on assets improvedROA up on the prior year0.5% → -6.5%
- Earnings backed by cashOperating cash flow above net income$49.91M vs -$55.42M
- Less leverageLong-term debt to assets fell4.9% → 5.0%
- Better liquidityCurrent ratio rose1.24 → 0.91
- No dilutionShare count did not rise63M → 63M
- Gross margin improvedGross margin up on the prior year40.14% → 39.30%
- More efficientAsset turnover rose0.57 → 0.39